Fiche publication
Date publication
mai 2017
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr KALBACHER Elsa
Tous les auteurs :
Pautier P, Kalbacher E, de la Motte Rouge T, Bonnetain F, Lesoin A
Lien Pubmed
Résumé
EARLY RELAPSE: Early relapse (primary or secondary) is defined by relapse of disease less than 6 months before the last infusion of chemotherapy (with a platinum compound). There is no carcinological surgical indication. Disease should be treated with a non-platinum single agent (pegylated liposomal doxorubicin, weekly paclitaxel, gemcitabine or topotecan). Bevacizumab can be added if patients have not already received it (level of proof 1, grade A).
Mots clés
Cancer de l’ovaire, Early relapse, Ovarian cancer, Rechute précoce
Référence
Bull Cancer. 2017 May;104 Suppl 1:S32-S38
